共 37 条
- [21] Laskow, D.A., Curtis, J.J., Posttransplant hypertension (1990) Amer J. Hypertens., 3, p. 721
- [22] Lindholm, A., Albrechtsen, D., Frödin, L., Ischemic heart disease - Major cause of death and graft loss after renal transplantation in Scandinavia (1995) Transplantation, 60, p. 451
- [23] Norman, D.J., Illingworth, D.R., Munson, J., Hosenpud, J., Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin (1988) N. Engl. J. Med., 46, p. 318
- [24] Raine, A.E.G., Carter, R., Mann, J.I., Morris, P.J., Adverse effects of CsA on plasma cholesterol in renal transplant recipients (1988) Nephrol. Dial. Transplant., 3, p. 458
- [25] Raine, A.E.G., Margreiter, R., Brunner, F.P., Ehrich, J.H.H., Geerlings, W., Landais, P., Loirat, C., Valderrabano, F., Report on management of renal failure in Europe, XXII, 1991 (1992) Nephrol. Dial. Transplant., 7 (2 SUPPL.), p. 7
- [26] Rostand, S.G., Kirk, K.A., Rutsky, E.A., Dialysis-associated ischemic heart disease: Insights from coronary angiography (1984) Kidney Int., 25, p. 653
- [27] Roth, D., Milgrom, M., Esquenazi, V., Posttransplant hyperglycemia: Increased incidence in CsA-treated renal allograft recipients (1989) Transplantation, 47, p. 278
- [28] Sánchez, J., Pallardö, L.M., Sánchez, P., Risk factors and prognostic significance of hypertension after renal transplantation (1992) Transplant. Proc., 24, p. 2738
- [29] Shihabi, Z.K., Konen, J.C., McCormick, C.P., Plasma fibrinogen levels in type II diabetics (1990) Clin. Physiol. Biochem., 8, p. 297
- [30] Sumrani, N., Delaney, V., Ding, Z., Posttransplant diabetes mellitus in CsA-treated renal transplant recipients (1991) Transplant. Proc., 23, p. 1249